Effect of tourniquet use on activation of coagulation in total knee replacement.
Total knee replacement often is performed with tourniquet application. The advantages of a dry field, including fixation, are well known, but it still is debatable if tourniquet application increases deep vein thrombosis. Measurement of coagulation markers is a well accepted method of studying thrombogenesis activation intraoperatively and postoperatively. Twenty patients undergoing total knee replacement with subarachnoid anesthesia were assigned randomly to two groups: either with tourniquet application (Group I) or without tourniquet application (Group II). There were no differences between patients in the two groups in terms of age, gender, diagnosis (all had osteoarthritis), operative time, and total (intraoperative and postoperative) blood loss. Markers for thrombin generation and fibrinolysis were measured. Blood samples were drawn at four times: baseline before the operation; after bone cuts; after cement fixation (Group II) or 2 minutes after tourniquet deflation (Group I); and 1 hour after surgery. Markers of thrombin generation and fibrinolysis showed a significant increase from baseline in all the patients. In Group II these markers started to increase during surgery, whereas in Group I the increase occurred at the end of the procedure when the tourniquet was deflated. The total amount of thrombin generation was significantly higher in Group II (without tourniquet), whereas fibrinolysis was significantly greater in Group I. Total knee replacement is accompanied by a hypercoagulative state with or without the use of a tourniquet, but it seems to be higher when the tourniquet is not used. In addition, tourniquet application may increase fibrinolysis.
Aglietti
P
P
Second Orthopaedic Clinic, University of Florence, Italy.
Baldini
A
A
Vena
L M
LM
Abbate
R
R
Fedi
S
S
Falciani
M
M
D000368:Aged; D019645:Arthroplasty, Replacement, Knee; D005260:Female; D005342:Fibrinolysis / Q000502:physiology; D006488:Hemostasis, Surgical; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000097:blood*; D012307:Risk Factors; D013917:Thrombin / Q000378:metabolism; D019851:Thrombophilia / Q000097:blood; D013924:Thrombophlebitis / Q000097:blood*; D014111:Tourniquets
D013917:Thrombin